Great Point Partners’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-400,000
| Closed | -$12M | – | 40 |
|
|
2022
Q1 | $12M | Sell |
400,000
-100,000
| -20% | -$2.99M | 2.89% | 16 |
|
|
2021
Q4 | $13.3M | Buy |
500,000
+302,000
| +153% | +$8M | 2.94% | 13 |
|
|
2021
Q3 | $7.19M | Buy |
198,000
+48,000
| +32% | +$1.74M | 1.67% | 26 |
|
|
2021
Q2 | $6.51M | Buy |
+150,000
| New | +$6.51M | 1.37% | 25 |
|
|
2018
Q3 | – | Sell |
-340,784
| Closed | -$9.64M | – | 34 |
|
|
2018
Q2 | $9.64M | Sell |
340,784
-517,161
| -60% | -$14.6M | 1.34% | 23 |
|
|
2018
Q1 | $30.4M | Buy |
857,945
+69,087
| +9% | +$2.45M | 4.51% | 11 |
|
|
2017
Q4 | $30.6M | Sell |
788,858
-121,711
| -13% | -$4.72M | 5.22% | 7 |
|
|
2017
Q3 | $23.1M | Hold |
910,569
| – | – | 4.5% | 7 |
|
|
2017
Q2 | $24.9M | Hold |
910,569
| – | – | 4.45% | 9 |
|
|
2017
Q1 | $30.1M | Buy |
+910,569
| New | +$30.1M | 5.99% | 5 |
|
|
2016
Q3 | – | Sell |
-5,000
| Closed | -$112K | – | 41 |
|
|
2016
Q2 | $112K | Sell |
5,000
-10,787
| -68% | -$242K | 0.03% | 35 |
|
|
2016
Q1 | $328K | Buy |
+15,787
| New | +$328K | 0.12% | 28 |
|